Monica Gandhi

When I take care of an HIV-infected woman in my clinic, I do not know if this new and exciting treatment or strategy applies specifically to her if the trial did not include enough people in their study that look like her.

health-news

I think it's hard to have a CEO dictate our policy and companies who stand and make money for it.

Remember, we were able to open schools safely in many parts of this country even prior to any vaccinations. We know the mitigation procedures that work, and they are masks and, frankly, ventilation.

[ J ] ust the fact that you have more circulating virus alone will make it more likely that you get a mild breakthrough infection. And the problem with a mild breakthrough infection is you can pass on to another and that other person, if they're unvaccinated, can get sick.

I know some states have said' No,' but we do need masks during The Delta variant. And then, I believe we need off-ramps for when those masks can come off for kids, because not everyone wants their children masked, and I think that's fair. But we need off-ramps when the community transmission rate is low, things seem really scary right now, because cases are increasing rapidly. But this will not continue forever.

It's normal for immunoglobulins to reduce over time.

It means something to people for it to be approved, it just seems like the simplest, easiest thing we could be doing right now.

I mean, in the sense that it’s true that if we did this across the nation, it would bring our death rate lower.

That's where we're getting to. So it's very good news.

Of course, not everyone stuck to their masks and distancing plans once they went inside, you obviously have to take your mask off to eat, and the virus spreads much more easily indoors.

There is an interesting two-sides-of-the-coin dance coming out between viral [ dose ] -- what goes in -- and viral load -- what comes out.

I don't think we're going to actually get to that value. We can in animals -- there's been a ferret model and there's been a hamster model -- now two animal models where the more you give them the more sick those animals get and that is helpful, and it may give us a sense. But we won't know with humans, unfortunately, how much it takes.

We're going to give them a teeny bit of virus and they're going to get just a teeny bit sick and then they'd develop an immune response -- and it totally worked.